- Weitere Informationen:
FamiCord Suisse S.A.
FamiCord Suisse S.A. (pre-rebranding name: Stemlab Group), was founded in 2003 as one of the first family cord blood banks in Europe. Stemlab is currently active in Portugal, Spain, Italy and Switzerland as a provider of the service of cryopreservation of the umbilical cord blood and tissue stem cells. Stemlab offers parents-to-be the possibility to isolate and cryopreserve stem cells from their children's umbilical cord blood and tissue for a minimum of 25 years. Cryopreservation of both types of cells allows their potential future application in the treatment of over 80 diseases during the lifetime of the newborn and/or his/her relatives. Stemlab boasts a young team, comprising graduates, masters and PhDs, which is a decisive factor in the quality of the services provided. During more than 10 years of operation Stemlab has stored more than 60 000 samples and released 8 samples for 13 transplants. Top specialists in the stem cell field collaborate with Stemlab in several R&D projects, these projects have given rise to the registration of 2 international patents for new treatments with stem cells. Stemlab is one of the founders of the Cord Blood Association and Cord Blood Europe, 2 international non-profit organizations composed by the leading private and public cord blood banks worldwide, with the mission of raising awareness on the benefits of adult stem cells and on the need to increase their storage at birth. Stemlab is certified by the ISO 9001:2000 for Quality Management Standards, a certification given by the German company, TUEV Rheinland, accredited by the American Association of Blood Banks (AABB), according to the Standards for Cellular Therapy Product Services for the activities related to the processing, storage and distribution of umbilical cord blood and fully authorized according to European Directives for cells and tissue banks.